Results 141 to 150 of about 1,483,664 (290)
Distributed Key Management to Secure IoT Wireless Sensor Networks in Smart-Agro. [PDF]
Mawlood Hussein S +2 more
europepmc +1 more source
An information-theoretic approach for design and analysis of rooted-tree-based multicast key management schemes [PDF]
Radha Poovendran, John S. Baras
openalex +1 more source
Abstract Rheumatoid arthritis (RA) is a chronic, highly disabling autoimmune disease. Although modern medical treatments have made progress, challenges such as suboptimal efficacy, relapse, difficulties in comorbidity management, and side effects persist.
Dier Jin +8 more
wiley +1 more source
A Configurational Perspective on Key Account Management [PDF]
Christian Homburg +2 more
openalex +1 more source
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia +20 more
wiley +1 more source
A WSN Layer-Cluster Key Management Scheme Based on Quadratic Polynomial and Lagrange Interpolation Polynomial. [PDF]
Wang X, Yang Z, Feng Z, Zhao J.
europepmc +1 more source
Central Dysmyelination in SSADH‐Deficient Humans and Mice
ABSTRACT Objectives Succinic semialdehyde dehydrogenase deficiency (SSADHD) is an inherited metabolic disorder characterized by an accumulation of γ‐aminobutyric (GABA). In addition to its synaptic role as an inhibitory neurotransmitter, GABA also plays an important role in myelination.
Itay Tokatly Latzer +11 more
wiley +1 more source
An efficient key management scheme for secure wireless multicast [PDF]
Yan Sun, Wade Trappe, K. J. Ray Liu
openalex +1 more source
ABSTRACT Objective Prognostication of disease course and prediction of treatment response in multiple sclerosis is an unmet need. We compared the performance of serum neurofilament light chain Z scores (age‐ and BMI‐adjusted) with absolute concentrations for the prediction of response to disease‐modifying therapy.
Maximilian Einsiedler +43 more
wiley +1 more source

